Equifax Inc.

(New York Stock Exchange)

Equifax (EFX) stock at a glance

Full Equifax report
Ticker
EFX
Exchange
New York Stock Exchange
News sentiment ยท last 30 days
+40 Somewhat Bullish โ–ฒ +21 vs. previous 30 days
30-day average of 9 articles ยท scale โˆ’100 to +100

Across 9 scored articles from Oct 16 to Nov 14, 2026 (UTC), the average sentiment of Equifax news is Somewhat Bullish (+40) on a scale from โˆ’100 to +100. That is up 21 points from the previous 30 days (+19).

+75 Bullish 1 article

Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.

Articles

45
Show Summary
Show Bulletpoints
Detailed View
Slightly Bullish +17

Equifax Announces Participation in Upcoming Investor Conferences

AI-generated analysis

Equifax (NYSE:EFX) has partnered with Ataeva to launch the Ataeva Product Suite, a strategic move designed to integrate Equifax credit data into portfolio optimization tools for lenders. This new suite utilizes proprietary analytics aimed at helping financial institutions refine credit decisioning and customer targeting, aligning with an industry trend where lenders seek more granular metrics and data-driven approaches for risk management and growth. By embedding its data more tightly into lender workflows, the partnership intends to potentially support increased usage of Equifax's credit analytics over time, addressing investor questions regarding how quickly these tools will be adopted and whether it leads to steadier demand for the company's services. The announcement occurs against a backdrop of challenging recent stock performance, with Equifax shares trading at $172.56. The company has experienced significant declines, including a 19.4% drop year-to-date and a 33.1% decrease over the past year, while three-year and five-year returns have fallen by 11.8% and 25.4%, respectively. Valuation data suggests the stock trades approximately 24% below its analyst price target range midpoint of $228.48 and is flagged by Simply Wall St as undervalued, trading 55.5% below its estimated fair value. However, recent price momentum has been soft, with a 30-day decline of roughly 2.7% leading up to this news. Investors are encouraged to monitor several key factors as the company implements these new strategic initiatives, including the pace of adoption by lenders and any disclosed revenue contribution from such partnerships. Additionally, analysis highlights that Equifax carries a high level of debt, prompting caution regarding how new product investments balance against leverage and interest costs. With an industry average P/E ratio of 20.4x serving as a reference point, the long-term success of this venture depends on whether the broader use of Equifax-powered analytics can stabilize demand and support steady growth for financial institutions leveraging its data.

๐Ÿค Equifax partners with Ataeva to integrate credit data into lender optimization tools.

๐Ÿ“‰ Stock is undervalued but faces high debt levels and recent share price declines.

โš ๏ธ Investors will monitor adoption speed and the impact on future revenue streams.

๐Ÿค Equifax (NYSE:EFX) has partnered with Ataeva to launch the Ataeva Product Suite, integrating credit data into portfolio optimization tools for lenders.

๐Ÿ“Š The new suite features proprietary analytics aimed at helping financial institutions refine credit decisioning and customer targeting strategies.

๐Ÿ“‰ Despite established in credit data, Equifax's shares have declined 19.4% year-to-date and 33.1% over the past year as of the announcement.

๐Ÿ’ฐ Currently trading at $172.56, the stock is noted as being approximately 24% below the midpoint of analyst price target ranges.

๐Ÿ“‰ Simply Wall St analysis flags Equifax shares as undervalued, trading 55.5% below its estimated fair value based on historical data.

โš ๏ธ Recent price momentum has been weak, with a roughly 2.7% decline in share price over the past 30 days leading into this news.

๐Ÿ”„ The partnership aims to deepen Equifax's role in credit analytics by tying its data more tightly into lender operational workflows.

๐Ÿ“ˆ Investors will be monitoring the speed of adoption by lenders and any potential revenue contribution from these new tools.

โš ๏ธ The company carries a high level of debt, which requires investors to track how new product investments balance against leverage.

๐Ÿค– This strategic move aligns with lenders seeking granular metrics and data-driven approaches for managing risk and growth.

โ“ A key question remains regarding whether broader use of Equifax-powered analytics will lead to steadier demand over time.

๐Ÿ“‹ Analysts suggest tracking the P/E ratio relative to the 20.4x industry average as a metric for financial health.

๐Ÿ›ก๏ธ Simply Wall St emphasizes that their analysis relies on fundamental data and historical information without representing recent price-sensitive announcements.

โš–๏ธ The article concludes with a disclaimer stating that the content is general in nature and does not constitute specific financial advice.

๐Ÿ“ง Readers can access further details, including company reports and community perspectives, through Simply Wall St's platform.

Bullish Signals
  • Equifax has partnered with Ataeva to launch the Ataeva Product Suite, introducing proprietary analytics designed to help financial institutions refine credit decisioning and customer targeting.
  • This new suite addresses the growing market demand from lenders seeking more granular metrics and data-driven approaches to managing risk and growth.
  • Equifax shares are currently trading at US$172.56, which is approximately 24% below the midpoint of the US$228.48 analyst price target range.
  • Simply Wall St valuation model flags Equifax shares as undervalued, with the stock trading 55.5% below its estimated fair value.
  • The partnership deepens Equifax's integration into lender workflows, which could support increased usage of its credit analytics and lead to steadier demand for its data and services over time.
Risk Factors
  • Equifax stock has experienced significant recent declines, dropping 19.4% year-to-date and falling 33.1% over the past year, indicating persistent investor skepticism.
  • Shares are trading at $172.56, which is 24% below the midpoint of the analyst price target range, suggesting the market currently undervalues the company's near-term potential.
  • The stock returned -2.7% over the last 30 days, showing negative momentum despite the new partnership announcement.
  • Equifax carries a high level of debt, creating concerns about how new product investments and strategic partnerships will affect leverage ratios and interest expenses.
  • The success of the Ataeva Product Suite is uncertain, with risks that lender adoption of these new analytics tools may be slower than expected or fail to generate steady demand.
Slightly Bullish +25

5 Must-Read Analyst Questions From Equifaxโ€™s Q1 Earnings Call

AI-generated analysis

Equifax reported a mixed bag of results for its first quarter, as revenue and adjusted earnings per share exceeded Wall Street expectations despite the stock trading lower on the day. The company generated $1.65 billion in revenue, marking a 14.3% year-over-year increase that surpassed analyst estimates by 2%, while adjusted EPS came in at $1.86, beating forecasts by 9.7%. This outperformance was largely driven by strong U.S. mortgage volumes in February, which benefited from new product launches such as the TWN Indicator and AI-driven cost savings initiatives. Although management noted a softening in activity for March due to higher interest rates and geopolitical concerns, they did slightly lift their full-year revenue guidance to $6.75 billion and raised adjusted EPS expectations to $8.54 per share at the midpoint. The quarter also saw an expansion in operating margins to 17.4%, up from 16.4% a year prior. During the earnings call, analysts focused heavily on the company's strategic differentiators and future growth catalysts. Discussions centered on the timing of government contract revenues amid state budget constraints and the pace of adoption for their VantageScore credit scoring model following regulatory changes. Management emphasized that while the pipeline for government deals is robust, revenue recognition remains complex due to activation timelines and budget cycles. Additionally, investors probed the impact of rising interest rates on auto and banking lending segments, with CEO Mark Begor noting some slowdown in auto financing but maintaining stability across other areas. Significant attention was also paid to the competitive landscape, specifically regarding potential disruption from new government verification tools and agentic AI; however, leadership argued that Equifax's proprietary data and integrated AI solutions continue to serve as strong protective barriers against such threats. Looking ahead, the company plans to monitor the adoption rates of its expanded TWN Indicator products across auto, card, and personal loan markets, aiming to capitalize on customer demand for no-cost pre-qualification and other credit checks. Executives expect technical readiness for VantageScore to be high, with pricing reductions anticipated to accelerate uptake once regulatory hurdles are cleared. The StockStory analysis highlights that the TWN Indicator has already begun contributing meaningfully to share gains, particularly in the mortgage pre-qualification space, based on early customer feedback. As Equifax navigates these developments, ongoing progress in converting government opportunities into active contracts and the execution of AI-driven productivity improvements will be critical factors for shareholders evaluating the company's trajectory beyond its current earnings beat.

๐Ÿ“ˆ Q1 revenue grew 14.3% to $1.65B, beating estimates and raising full-year guidance.

๐Ÿค– VantageScore is technically ready; pricing cuts should accelerate adoption in key sectors.

๐Ÿ  Strong U.S. mortgage volume drove growth despite auto financing slowdowns from high rates.

- ๐Ÿ“ˆ Equifax Q1 revenue reached $1.65 billion, beating Wall Street estimates of $1.62 billion with 14.3% year-over-year growth.

- ๐Ÿ’ฐ Adjusted EPS hit $1.86, significantly surpassing the $1.70 analyst consensus estimate.

- ๐Ÿ“‰ Despite earnings beats, the market reacted negatively as shares dropped from $198.45 to $172.80 following the report.

- ๐Ÿ  Strong growth in U.S. mortgage volumes in February drove performance through new TWN Indicator product rollouts.

- ๐Ÿงช Revenue recognition timing depends on complex activation timelines and state government budget cycles.

- ๐Ÿค– Management claims VantageScore technical readiness is high, with pricing reductions expected to accelerate adoption.

- ๐Ÿš— Auto financing segments experienced a slowdown due to rising interest rates but remain broadly stable.

- ๐Ÿ’ก The TWN Indicator contributed meaningfully to share gains, particularly in mortgage pre-qualification markets.

- ๐Ÿ”’ Equifax maintains competitive advantage through proprietary data and integrated AI solutions against external threats.

- ๐Ÿ’ผ Full-year revenue guidance was slightly lifted to a midpoint of $6.75 billion from the previous $6.72 billion.

- ๐Ÿ“Š Adjusted EPS guidance for the full year was raised to a midpoint of $8.54.

- โš–๏ธ Operating margin expanded to 17.4%, up from 16.4% in the same quarter last year.

- ๐Ÿข Management noted a slight softening in transactional activity in March due to geopolitical uncertainties and rate hikes.

- ๐Ÿ‘€ Analysts are monitoring adoption rates of TWN products across auto, card, and personal loan sectors.

- โณ Progress will be tracked on converting government pipeline opportunities into active contracts despite hurdles.

- ๐Ÿง  StockStory team plans to watch AI-driven productivity improvements and broader economic shifts as critical markers.

Bullish Signals
  • Q1 revenue reached $1.65B, up 14.3% year-over-year.
  • Adjusted EPS hit $1.86, beating estimates by 9.7%.
  • Full-year revenue guidance raised to $6.75 billion.
  • Full-year Adjusted EPS guidance increased to $8.54.
  • Operating margin expanded robustly by 29%.
  • Mortgage volumes surged in February with new AI tools.
  • TWN Indicator delivers meaningful share gains in pre-qualification.
  • Proprietary data limits disruption from government verification tools.
Risk Factors
  • Stock price fell 13% despite beating estimates.
  • Rising rates and geopolitics dampened mortgage activity.
  • VantageScore growth delayed pending regulatory approval.
  • Government contract revenue faces budget timing risk.
  • Competitive AI tools threaten core data business.
  • Auto financing slowdown signals segment weakness.
Bullish Signals
  • Equifax's Q1 revenue of $1.65 billion surpassed analyst estimates by $24 million, representing strong 14.3% year-over-year growth.
  • The company beat analyst expectations for Adjusted EPS significantly, reporting $1.86 versus the estimated $1.70 (a 9.7% beat).
  • Equifax slightly raised its full-year revenue guidance to $6.75 billion at the midpoint, signaling management confidence in future demand.
  • Management also increased its full-year Adjusted EPS guidance to $8.54 at the midpoint after reporting a robust 29% operating margin expansion.
  • Strong growth in U.S. mortgage volumes during February was driven by new product rollouts like the TWN Indicator and AI-driven cost productivity.
  • The TWN Indicator is resonating with customers, providing proof points that the company's differentiated solutions are gaining market traction.
  • Early contributions from the TWN Indicator have already shown meaningful share gains, particularly in mortgage pre-qualification segments.
  • Equifax's proprietary data and integrated AI solutions remain key differentiators, effectively limiting potential disruption from competitive government verification tools.
Risk Factors
  • Equifax's stock price dropped from $198.45 to $172.80 immediately following the earnings report, indicating negative market sentiment despite beating revenue and earnings estimates.
  • Mortgage and other transactional activity softened significantly in March due to rising interest rates and geopolitical uncertainties, which could dampen near-term growth.
  • Toni Kaplan (Morgan Stanley) noted that the pace of VantageScore adoption is contingent on regulatory approvals, introducing potential delays to this key growth initiative.
  • Jeffrey Meuler (Baird) highlighted that while the pipeline is robust, actual revenue recognition from government contracts is complex and subject to budget cycles and activation timelines, creating uncertainty in cash flow timing.
  • Ashish Sabadra (RBC Capital Markets) raised concerns about competitive threats emerging from new government verification tools and agentic AI, posing a potential disruption risk to Equifax's data business.
  • Manav Patnaik (Barclays) reported that auto financing experienced some slowdown amidst rising rates, signaling weakness in one of the company's core credit scoring segments.
  • The market may be discounting future earnings given the headwinds from higher interest rates and geopolitical instability, despite management highlighting strong Q1 performance.
Neutral +5

Equifax Expands Revolving Credit Facility to Boost Liquidity

AI-generated analysis

On April 23, 2026, Equifax Inc. and several of its international subsidiaries announced an amendment to their existing revolving credit agreement aimed at enhancing liquidity and financial flexibility. The company expanded its unsecured revolving credit facility from $1.5 billion to $2 billion, while increasing swingline loan availability from $150 million to $200 million. Additionally, the agreement removes a 10 basis point credit spread adjustment on Term SOFR borrowings and extends the termination date for $1.9 billion of the facility by one year to August 25, 2029. The remaining $100 million portion of the facility continues to mature on August 25, 2028, which maintains a staggered maturity profile intended to help manage refinancing risk over time. Equifax stated that these modifications are designed to support its ongoing funding needs across global operations and could strengthen its capacity to invest, refinance, or manage working capital within the competitive financial data and analytics market. The company describes itself as a global provider of credit information, risk assessment, identity verification, and related financial data services for lenders, businesses, and governments in markets including the U.S., Canada, Europe, and the Asia-Pacific region. While core terms of the agreement remain unchanged, the expansion is viewed as a strategic move to bolster capital resources without altering the fundamental structure of its debt obligations. In terms of market reception and analysis, the most recent analyst rating on Equifax (EFX) stock is a Buy with a price target of $220.00. However, Spark, TipRanks' AI Analyst, rates EFX as Neutral. This neutral score reflects a balance between positive factors, such as solid underlying financial performance, growth, strong absolute free cash flow, improving margins, and reaffirmed cash generation from a constructive earnings update. These positives are tempered by concerns regarding high leverage, weaker cash conversion quality signals, an expensive stock valuation, and technical indicators showing only a partial recovery within a longer-term downtrend.

๐Ÿ“ˆ Credit facility expands from $1.5B to $2 billion with extended maturity.

๐Ÿ“‰ 10 basis point spread adjustment removed while liquidity flexibility improves.

๐Ÿ’ฐ Analysts hold mixed Buy and Neutral ratings on Equifax stock.

๐Ÿฆ Strong performance faces offsetting concerns over high leverage and valuation.

๐Ÿ“ˆ Equifax amended its revolving credit agreement on April 23, 2026, expanding the unsecured facility from $1.5 billion to $2 billion.

๐Ÿ’ฐ The company increased swingline loan availability from $150 million to $200 million under the new terms.

๐Ÿ“‰ A 10 basis point credit spread adjustment on Term SOFR borrowings was removed as part of the amendment.

๐Ÿ“… The termination date for $1.9 billion of the facility was extended by one year to August 25, 2029.

๐Ÿ›ก๏ธ These changes are designed to enhance Equifax's liquidity profile and financial flexibility without altering core agreement terms.

๐ŸŒ The expanded credit support global operations across the U.S., Canada, Europe, and the Asia-Pacific region.

๐Ÿ’ผ Analysts maintain a Buy rating on EFX stock with a price target of $220.00.

๐Ÿค– Spark AI's TipRanks analyst rates EFX as Neutral due to mixed signals regarding leverage and valuation.

โš–๏ธ The company's strong financial performance is offset by concerns over high leverage and expensive valuation.

๐Ÿฆ Equifax operates in the consumer credit reporting industry providing data services to lenders and governments.

Bullish Signals
  • Equifax expanded its unsecured revolving credit facility from $1.5 billion to $2 billion, providing enhanced liquidity and financial flexibility.
  • The amendment removed a 10 basis point credit spread adjustment on Term SOFR borrowings, reducing financing costs.
  • The termination date for $1.9 billion of the facility was extended by one year to August 25, 2029, improving refinancing stability.
  • Analysts maintain a Buy rating with a $220.00 price target, indicating positive sentiment on EFX stock.
  • The company demonstrated solid underlying financial performance with growth and strong absolute free cash flow.
  • Equifax delivered a constructive earnings update featuring improving margins and reaffirmed cash generation capabilities.
Risk Factors
  • The company's valuation is considered expensive according to Spark analysis.
  • Technical indicators show only a partial recovery within a longer-term downtrend, suggesting underlying bearish pressure.
  • Cash conversion quality signals are weaker than ideal despite solid financial performance.
  • Equifax maintains high leverage levels which poses a risk in rising interest rate environments.
Somewhat Bullish +50

Equifax Announces Earnings Release Date and Conference Call for First Quarter 2026 Results

AI-generated analysis

Equifax Inc. (EFX), a global data and analytics firm with a market capitalization of $22 billion, has set a date to announce its fiscal first quarter 2026 earnings results. The company, headquartered in Atlanta, Georgia, operates through segments including Workforce Solutions, U.S. Information Solutions, and International, offering credit analytics, identity verification, and HR automation services worldwide. Ahead of the Q1 2026 report, analysts anticipate an adjusted earnings per share (EPS) of $1.69, representing a 10.5% increase from the $1.53 reported in the year-ago quarter, following four consecutive quarters where Equifax has exceeded Wall Street's bottom-line estimates. Looking further ahead, market expectations for Equifax's fiscal performance show strong projected growth, with analysts expecting adjusted EPS of $8.61 for fiscal 2026, up 12.6% from the $7.65 reported in fiscal 2025. This trend is expected to continue into fiscal 2027, where adjusted EPS could reach $10.30, marking a 19.6% year-over-year increase. The company's stock performance has been mixed over the past year; shares have declined by 26.3% over the last 52 weeks, significantly lagging behind the S&P 500 Indexโ€™s nearly 22% gain and the State Street Industrial Select Sector SPDR ETFโ€™s 23.1% return during the same period. Investor sentiment was recently bolstered by a 3.4% rise in shares on February 4 following the Q4 2025 earnings report, which showed revenue of $1.55 billionโ€”a 9% year-over-year increase that surpassed guidance estimates despite challenges in the U.S. hiring and mortgage markets. Specific segments demonstrated resilience with 20% growth in U.S. Mortgage revenue, 12% growth in USIS, 9% growth in Workforce Solutions, and a record Vitality Index of 17%. Currently, Equifax holds a "Moderate Buy" consensus rating from 25 analysts, divided between 12 "Strong Buys," three "Moderate Buys," and 10 "Holds," with an average price target of $235.57 implying potential upside of 29.2% from current levels. The article concludes by noting the publication date disclaimer regarding author positions in securities and credits the original source as Barchart.com.

๐Ÿ“ˆ Analysts forecast Q1 2026 EPS of $1.69, up 10.5% year-over-year

๐Ÿ“Š Full-year 2027 adjusted EPS expected to hit $10.30, a 19.6% increase

โฌ‡๏ธ Shares dropped 26.3% over 52 weeks despite recent revenue beats and strong guidance

๐Ÿ“… Equifax is preparing to release its fiscal Q1 2026 earnings results and schedule a conference call soon.

๐Ÿ“Š Analysts expect adjusted EPS of $1.69, representing a 10.5% increase from the previous year's $1.53.

๐Ÿš€ The company has exceeded Wall Street bottom-line estimates for four consecutive quarters.

๐Ÿ“ˆ For fiscal 2026, analysts project adjusted EPS of $8.61, a 12.6% rise from fiscal 2025's $7.65.

๐Ÿ”ฎ Adjusted EPS is anticipated to grow 19.6% year-over-year to $10.30 in fiscal 2027.

๐Ÿ“‰ Equifax shares have dropped 26.3% over the last 52 weeks, significantly underperforming the S&P 500 and XLI ETF.

โฌ†๏ธ Stock rose 3.4% on Feb. 4 following Q4 2025 results that showed $1.55 billion revenue, up 9% year-over-year.

๐Ÿ“ฆ Revenue growth was driven by strong performance in U.S. Mortgage (+20%), USIS (+12%), Workforce Solutions (+9%), and a record Vitality Index of 17%.

โš–๏ธ Analyst consensus is "Moderate Buy," with 12 out of 25 analysts rating it as "Strong Buy."

๐ŸŽฏ The average price target stands at $235.57, implying potential upside of 29.2% from current levels.

๐ŸŒ Equifax operates through three main segments: Workforce Solutions, U.S. Information Solutions, and International.

๐Ÿ’ฐ Market cap is estimated at $22 billion.

๐Ÿ›ก๏ธ Services include credit analytics, identity verification, and employment automation across multiple countries.

โš ๏ธ Recent stock performance faced headwinds including weak U.S. hiring and mortgage markets despite strong segment growth.

๐Ÿ“ฐ All information provided in the article is for informational purposes and not financial advice.

Bullish Signals
  • EPS projected to rise 10.5% to $1.69 in Q1 2026
  • Beat bottom-line estimates for four consecutive quarters
  • Full-year 2026 EPS growth of 12.6% to $8.61
  • EPS expected to grow 19.6% to $10.30 in 2027
  • Shares up 3.4% on Q4 2025 revenue beat of $30M
  • U.S. Mortgage, USIS, Workforce Solutions and Vitality Index all grew
  • Consensus rating: Moderate Buy with 12 Strong Buy ratings
  • Potential upside of 29.2% from current price to $235.57 target
Risk Factors
  • Equifax shares down 26.3% over 52 weeks, lagging S&P 500
  • Only 17 of 25 analysts rate stock 'Buy'; 10 are 'Hold'
  • Market threats: Tesla falling, Iran war, inflation risks
Bullish Signals
  • Analysts expect Equifax's adjusted EPS for fiscal Q1 2026 to reach $1.69, representing a 10.5% increase from the year-ago quarter of $1.53.
  • Equifax has surpassed Wall Street's bottom-line estimates in the past four consecutive quarters, demonstrating consistent performance above expectations.
  • Full-year fiscal 2026 adjusted EPS is projected to grow 12.6% to $8.61 compared to $7.65 in fiscal 2025.
  • Looking further out, analysts anticipate adjusted EPS will increase 19.6% year-over-year to $10.30 in fiscal 2027.
  • Equifax shares gained 3.4% on Feb. 4 following Q4 2025 revenue of $1.55 billion, which was up 9% year-over-year and $30 million above the midpoint of guidance.
  • Strong segment performance was highlighted, with U.S. Mortgage revenue growing 20%, USIS rising 12%, Workforce Solutions advancing 9%, and Vitality Index hitting a record 17%.
  • Analyst consensus rating is "Moderate Buy," with 12 out of 25 analysts assigning a "Strong Buy" rating to Equifax stock.
  • The average analyst price target of $235.57 suggests a potential upside of 29.2% from current levels.
Risk Factors
  • Shares of Equifax have decreased 26.3% over the past 52 weeks, significantly lagging behind the S&P 500 Index's nearly 22% gain and the State Street Industrial Select Sector SPDR ETF's (XLI) 23.1% return over the same period.
  • Analyst consensus rating is cautious with only 17 out of 25 analysts rating the stock as 'Strong Buy' or 'Moderate Buy,' while 10 give it a 'Hold' rating.
  • Despite recent Q4 2025 revenue beats, the broader context mentions Tesla Stock Keeping Falling and Iran War/Inflation Reading as key market threats that could negatively impact Equifax.
Somewhat Bearish -25

Is Equifax Stock Underperforming the S&P 500?

AI-generated analysis

Equifax Inc. (EFX) faces significant underperformance relative to the broader market, having dropped 31.8% from its May 2025 peak of $281.03 while trading below its 50-day and 200-day moving averages since September 2024. The stock has fallen 26.4% over six months and 20% over the past year, trailing the S&P 500, which gained 2.9% over the same six-month period and rose 21.6% last year. Equifax's decline is also outpacing industry rival TransUnion (TRU), which saw a 23% drop over six months and a 13% decline over the past year, suggesting sector-wide headwinds beyond Equifax alone. Despite this bearish trend and recent volatility, including a 13.2% plunge in the last three months, Equifax maintains its status as one of the three major U.S. credit bureaus with a $25.9 billion market cap, providing essential data infrastructure for mortgage approvals, credit card issuance, employment verification, and lending risk evaluation. On February 25, shares rose 2% following a board-approved dividend increase of 12%, raising the quarterly payout to $0.56 per share with a record date of March 9, 2026, and payment on March 17, 2026. This move reinforces Equifaxโ€™s long-standing commitment to shareholder capital returns, evidenced by more than a century of consecutive dividend payments. Analyst sentiment remains cautiously positive among the 25 analysts covering the stock, which hold a consensus "Moderate Buy" rating with a mean price target of $236.57, implying approximately 23.5% upside from current levels. However, the company has not disclosed recent Q4 earnings results or specific guidance in this update, meaning investor attention currently focuses on how Equifax can sustain its dividend streak and regain market footing amidst broader credit sector weakness and high interest rate sensitivity.

๐Ÿข Equifax is a top U.S. credit bureau with a $25.9 billion market cap.

๐Ÿ“‰ Shares are down 26.4% over six months while technicals remain bearish.

๐Ÿ’ฐ Company raised its quarterly dividend by 12% to $0.56 per share.

๐Ÿค Analysts rate Equifax a "Moderate Buy" with 23.5% upside potential to $236.57.

๐Ÿข Equifax Inc. (EFX) is a major U.S. data analytics and credit reporting firm with a $25.9 billion market cap, operating alongside Experian and TransUnion as one of the three primary credit bureaus.

๐Ÿ“Š The company facilitates critical financial functions such as mortgage approvals, credit card issuance, and employment verification by providing risk evaluation tools to lenders and government agencies.

๐Ÿ“‰ EFX stock has significantly underperformed the S&P 500, dropping 13.2% in the past three months compared to a mere 1.8% decline for the index.

๐Ÿ“… On a six-month basis, Equifax shares have fallen 26.4% while the S&P 500 rose 2.9%, and over the past year EFX is down 20% versus a 21.6% gain for the broader market.

๐Ÿ“‰ The stock hit a high of $281.03 on May 16, 2025, and is currently trading roughly 31.8% below that peak level.

๐Ÿ“‰ Technical indicators show EFX has been trading below its 50-day and 200-day moving averages since early September, indicating a sustained bearish trend.

๐Ÿ’ฐ Despite the stock decline, Equifax recently announced a 12% increase in its quarterly dividend to $0.56 per share, payable on March 17, 2026.

๐Ÿ•ฏ๏ธ This new dividend marks another step in the company's century-long streak of returning capital to shareholders, signaling financial strength and confidence in future cash generation.

๐Ÿค Industry rival TransUnion has also struggled recently, experiencing a 23% drop over six months and a 13% plunge over the past 52 weeks.

๐Ÿง‘โ€โš–๏ธ Analysts covering Equifax hold a consensus rating of "Moderate Buy," with a mean price target of $236.57 suggesting approximately 23.5% upside potential from current levels.

๐Ÿ“ข The article was published by Barchart.com and written by Kritika Sarmah, who disclosed no personal positions in the securities mentioned.

Bullish Signals
  • Equifax shares rose 2% on a 12% dividend increase.
  • New quarterly dividend is $0.56 per share.
  • Company maintains over one century of dividend payments.
  • Analysts consensus rating is 'Moderate Buy' for EFX.
  • Mean price target implies 23.5% upside potential.
Risk Factors
  • Stock trades 31.8% below its $281.03 52-week high.
  • Shares plunged 13.2% in three months versus S&P's 1.8% drop.
  • Stock down 26.4% over six months vs S&P 5 gains.
  • Possessing bearish technical trend below key moving averages.
  • Rival TransUnion (TRU) declined comparable 23% over six months.
  • $236.57 price target implies 23.5% downside at current prices.
Bullish Signals
  • On Feb. 25, Equifax shares climbed about 2% after the company announced a 12% increase in its quarterly dividend, signaling confidence in its financial strength.
  • The board approved a new quarterly dividend of $0.56 per share, payable on March 17, 2026, supporting a long-standing commitment to returning capital to shareholders.
  • Equifax has maintained an impressive dividend-paying streak spanning more than a century, highlighting its stability and consistent performance.
  • Among the 25 analysts covering the EFX stock, the consensus rating is a 'Moderate Buy,' indicating positive sentiment from industry experts.
  • The mean price target of $236.57 suggests a 23.5% upside potential from current price levels, providing a clear bullish catalyst for investors.
Risk Factors
  • Equifax stock is trading 31.8% below its 52-week high of $281.03, indicating significant downside from recent peaks.
  • Over the past three months, EFX shares have plunged 13.2%, outpacing the S&P 500's modest 1.8% fall and signaling weakness relative to the broader market.
  • The stock has declined 26.4% over six months and 20% in the past 52 weeks, contrasting sharply with the S&P 500's gains of 2.9% and 21.6% respectively during those same periods.
  • Equifax has traded mostly below its 50-day and 200-day moving averages since early September, underscoring a persistent bearish technical trend.
  • The company faces headwinds similar to its top rival TransUnion (TRU), which has suffered a comparable decline of 23% over the past six months.
  • While analysts offer a 'Moderate Buy' rating, the consensus mean price target of $236.57 still implies a 23.5% downside gap if current elevated prices persist.